At close: January 7 at 4:00:01 PM EST
Pre-Market: 4:48:13 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
FORBES ALEXANDRIA Chief Executive Officer | Stock Gift | Apr 5, 2024 | 1,401,490 |
GIROUX RICHARD Chief Operating Officer | Stock Gift | May 28, 2024 | 927,578 |
HARRIS KEITH R Director | Conversion of Exercise of derivative security | Jun 5, 2024 | 50,000 |
INDYK MARTIN Director | Conversion of Exercise of derivative security | Jun 5, 2024 | 35,000 |
NAYLOR STUART Officer | Conversion of Exercise of derivative security | Jan 12, 2024 | 564,329 |
PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 12, 2024 | -- |
WOLLIN ROBERT J General Counsel | Conversion of Exercise of derivative security | Jan 12, 2024 | 15,137 |
ZELDIN ROBERT K Officer | Conversion of Exercise of derivative security | Jan 12, 2024 | 89,724 |
Related Tickers
ACIU AC Immune SA
2.9300
-1.68%
JSPR Jasper Therapeutics, Inc.
17.71
-15.14%
RGNX REGENXBIO Inc.
8.36
+2.08%
VYGR Voyager Therapeutics, Inc.
5.92
-1.66%
OBIO Orchestra BioMed Holdings, Inc.
5.62
-0.71%
LXEO Lexeo Therapeutics, Inc.
7.33
+2.81%
ZNTL Zentalis Pharmaceuticals, Inc.
2.9900
-4.47%
ACRV Acrivon Therapeutics, Inc.
6.30
-7.22%
YMAB Y-mAbs Therapeutics, Inc.
7.65
-2.05%
XLO Xilio Therapeutics, Inc.
1.0050
-0.50%